Depressive symptoms and mortality in men: Results from the multiple risk factor intervention trial

Stroke

Volumn 36, Issue 1, 2005, Pages 98-102

  Gump, Brooks B ^a   Matthews, Karen A ^b   Eberly, Lynn E ^c   Chang, Yue Fang ^d  

^a STATE UNIVERSITY OF NEW YORK AT OSWEGO   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cardiovascular diseases; Depression; Stroke

Indexed keywords

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CIGARETTE SMOKING; DEPRESSION; EDUCATION; HIGH RISK POPULATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RACE; RISK FACTOR;

ADULT; CARDIOVASCULAR DISEASES; CEREBROVASCULAR ACCIDENT; CORONARY DISEASE; DEPRESSION; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MORTALITY; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS;

EID: 11144236264     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000149626.50127.d0     Document Type: Article

References (24)

1. Wulsin LR, Vaillant GE, Wells VE. A systematic review of the mortality of depression. Psychosom Med. 1999;61:6-17.
2. Ariyo AA, Hann M. Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Circulation. 2000;102: 1773-1779.
3. Herrman C, Brand-Driehorst S, et al. Diagnostic groups and depressed mood as predictors of 22-month mortality in medical inpatients. Psychosom Med. 1998;60:570-577.
4. Musselman DL, Evans DL, Nemeroll CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;1998:580-592.
5. Banki CM, Karmasci L, Bissette G, Nemeroff CB. CSF, corticotropin- releasing, and somatostatin in major depression: response to antidepressant treatment and relapse. Eur Neuropsychopharm. 1992;2:107-113.
6. Carney RM, Rich MW, teVelde A et al. Heart rate, heart rate variability and depression in patients with coronary artery disease. J Psychosom Res. 1988;32:159-164.
7. Jiang W, Babyak M, Krantz DS, et al. Mental stress-induced myocardial ischemia and cardiac events. JAMA. 1996;21:1651-1656.
8. Markovitz JH, Matthews KA. Platelets and coronary heart disease: potential psychophysiological mechanism. Psychosom Med. 1991;324: 781-788.
9. Jiang W, Krishnan RRK, O'Connor CM. Depression and heart disease: evidence of a link, and its therapeutic implications. CNS Drugs. 2002; 16:111-127.
10. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psych Measure. 1977;1:385-401.
11. Neaton JD, Grimm RHJ, Cutler JA. Recruitment of participants for the Multiple Risk Factor Intervention Trial (MRFIT). Controlled Clin Trials. 1987;8:41S-53S.
12. Benfari RC. Multiple Risk Factor Intervention Trial (MRFIT), III: the model for intervention. Prev Med. 1981;10:426-442.
13. Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Brit J Prev Soc Med. 1977;31: 42-48.
14. MRFIT Research Group. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention. Trial. Am J Card. 1985;55:1-15.
15. Anonymous. International Classification of Diseases, North American Clinical Modification, vol 1. Ann Arbor, MI: Edwards; 1981.
16. Wentworth D, Neaton JD, Rasmussen W. An evaluation of the Social Security Administration Master Beneficiary Record File and the National Death Index in the ascertainment of vital status. Am J Pub Health. 1983;73:1270-1274.
17. Jonas BS, Mussolino ME. Symptoms of depression as a prospective risk factor for stroke. Psychosom Med. 2000;62:463-471.
18. Simonsick EM, Wallace RB, Blazer DG, Berkman LF. Depressive symptomatology and hypertension-associated morbidity and mortality in older adults. Psychosom Med. 1995;57:427-435.
19. Steffens DC, Helms MJ, Krishnan KR, Burke GL. Cerebrovascular disease and depression symptoms in the cardiovascular health study. Stroke. 1999;30:2159-2166.
20. Wassertheil-Smoller S, Applegate WB, Berge K, Chang CJ, Davis BR, Grimm R Jr, Kostis J, Pressel S, Schron E. Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the Elderly Project). Arch intern Med. 1996; 156:553-561.
21. Penninx BWJH, Beekman ATF, Honig A, Deeg DJH, Schoevers RA, van Eijk JTM, Willem van Tilburg W. Depression and cardiac mortality: results from a community-based longitudinal study. Arch Gen Psychiatry. 2001;58:221-227.
22. Wassertheil-Smoller S, Shumaker S, Ockene J, Talavera GA, Greenland P, Cochrane B, Robbins J, Aragaki A, Dunbar-Jacob J. Depression and cardiovascular sequelae in postmenopausal women. Arch Intern Med. 2004;164:289-298.
23. Emberson J, Whincup P, Morris R, Walker M, Ebrahim S. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J. 2004;25:484-491.
24. Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation. 1999;99:2192-2217.